Acceptance rate, hesitancy and comorbidities in pregnant women: A COVID-19 vaccination status

Shah Zeb; Muhammad Naveed; Mariam Danish Iqbal; Faisal Shahzad; Muhammad Hassan; Muhammad Fayyaz Khan; Shawal Khan; Sumaira Salahuddin Lodhi; Azhar Abbas; Kaleem Ullah; Abbas Ahmad; Farman Ali; Shafiq Ur Rahman; Qazi Sami Ul Haq

doi:10.53730/ijhs.v7nS1.14162

Authors

Shah Zeb Department of Microbiology, University of Haripur, Haripur/ Department of Microbiology, Pakistan Kidney and Liver Institute & Research Center, Lahore 54000. Pakistan
Muhammad Naveed Department of Microbiology, Hazara University Mansehra Pakistan
Mariam Danish Iqbal Assistant Professor at Shalamar Institute of Health Sciences, Lahore Pakistan
Faisal Shahzad M.Phill Hematology at Riphah International University Pakistan
Muhammad Hassan Department of Medical Lab Technology, University of Haripur Pakistan
Muhammad Fayyaz Khan Department of Medical Lab Technology, University of Haripur Pakistan
Shawal Khan Department of Zoology, Quaid-i-Azam University, Islamabad Pakistan
Sumaira Salahuddin Lodhi Department of Biochemistry, Hazara University Mansehra Pakistan
Azhar Abbas Department of Biochemistry, Hazara University Mansehra Pakistan
Kaleem Ullah Department of Microbiology, Abbottabad University of Science and Technology, Abbottabad Pakistan
Abbas Ahmad Department of Microbiology, University of Haripur, Haripur Pakistan
Farman Ali Department of Microbiology, Hazara University Mansehra Pakistan
Shafiq Ur Rahman Department of Microbiology, Abbottabad University of Science and Technology, Pakistan
Qazi Sami Ul Haq Department of Microbiology, Abbottabad University of Science and Technology, Pakistan

Keywords:

Comorbidities, Hesitancy and Acceptance rate of COVID-19, Brand Preference, E-data

Abstract

We analyzed the electronic data (e-data) of n=5231 vaccinated candidates including n=3671 males and n=1560 females. We studied the COVID-19 vaccine brands such as Sino pharm, CanSino, SinoVac, Moderna and Pfizer. We noted adverse effects in post-vaccinated candidates were Instability in blood pressure 29.5%, Swelling 3.5%, Redness 14.2%, Itching 7.13%, and Rashes 2.4%. Comorbidities in the vaccinated candidates such as Hypertension 33%, Diabetes mellitus 17%, Kidney disease 42%, and Chronic respiratory disease 9%. COVID-19 vaccine hesitancy 1153, 22% and Non-Hesitant 4078, 77%. We analyzed the e-data of COVID-19 vaccinated candidates, the acknowledgement of COVID-19 immunization in pregnant women. Worrying about vaccine safety was the significant justification for hesitancy. Recognizing mentalities among study groups will be valuable for coming up with vaccine strategies that increment the ongoing pandemic.

Downloads

Download data is not yet available.

References

Center LPJN. Evaluation of Blood parameters, COVID-19 Vaccine Adverse effects, Hesitancy, and Acceptance rate in Pregnant Women: A Cross-sectional study. 2023;21(3):78-87.

Fauci AS, Lane HC, Redfield RRJNEJoM. COVID-19—navigating the uncharted. Mass Medical Soc; 2020. p. 1268-9.

Scalinci SZ, Battagliola ETJI. Conjunctivitis can be the only presenting sign and symptom of COVID-19. 2020;20:e00774.

y Galán JTGJN. Stroke as a complication and prognostic factor of COVID-19. 2020;35(5):318-22.

Le TT, Andreadakis Z, Kumar A, Román RG, Tollefsen S, Saville M, et al. The COVID-19 vaccine development landscape. 2020;19(5):305-6.

Ibrahim NKJJoi, health p. Epidemiologic surveillance for controlling COVID-19 pandemic: types, challenges and implications. 2020;13(11):1630-8.

French M, Monahan TJS, Society. Dis-ease surveillance: How might surveillance studies address COVID-19? 2020;18(1):1-11.

Organization WH. Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance, 20 March 2020. World Health Organization; 2020.

Syed Anwar Aly SA, Abdul Rahman R, Sharip S, Shah SA, Abdullah Mahdy Z, Kalok AJIjoer, et al. Pregnancy and COVID-19 pandemic perception in Malaysia: A cross-sectional study. 2021;18(11):5762.

Yang Z, Wang M, Zhu Z, Liu YJTjom-f, medicine n. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review. 2022;35(8):1619-22.

Wang C-L, Wu C-H, Wang C-Y, Wang C-H, Long C-YJIjoms. Impact of COVID-19 on Pregnancy. 2021;18(3):763.

Schmid MB, Fontijn J, Ochsenbein-Kölble N, Berger C, Bassler DJTLID. COVID-19 in pregnant women. 2020;20(6):653.

Liu H, Wang L-L, Zhao S-J, Kwak-Kim J, Mor G, Liao A-HJJori. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. 2020;139:103122.

London V, McLaren Jr R, Atallah F, Cepeda C, McCalla S, Fisher N, et al. The relationship between status at presentation and outcomes among pregnant women with COVID-19. 2020;37(10):991-4.

Rasmussen SA, Jamieson DJJO, gynecology. Coronavirus disease 2019 (COVID-19) and pregnancy: responding to a rapidly evolving situation. 2020.